Literature DB >> 20462895

Mortality predictors in ST-elevated myocardial infarction patients undergoing coronary artery bypass grafting.

Ugur Filizcan1, Erol Kurc, Sebnem Cetemen, Ozer Soylu, Hakki Aydogan, Olgar Bayserke, Muruvvet Yilmaz, Huseyin Uyarel, Mehmet Ergelen, Gokcen Orhan, Murat Ugurlucan, Ergin Eren, Ibrahim Yekeler.   

Abstract

The use of coronary artery bypass grafting (CABG) in primary treatment of acute myocardial infarction is still debated. We evaluated the predictors of mortality in patients undergoing primary CABG for ST-elevated myocardial infarction (STEMI). Between January 2003 and January 2008, all patients referred to our institution with STEMI who did not qualify for primary angioplasty and required CABG were included in this study. Survivors and nonsurvivors were compared retrospectively in terms of demo-graphics, preoperative, intraoperative, and postoperative characteristics. Preoperatively confirmed cases of STEMI (n = 150) were included in the analysis. There were 114 survivors and 36 nonsurvivors. In-hospital mortality rate was 22%. In Cox regression analysis age, cardiogenic shock (Killip ≥3), preoperative cardiac troponin levels, preoperative use of intra-aortic balloon counterpulsation (IABP), previous myocardial infarction, and percutaneous coronary intervention were independent predictors of in-hospital mortality. After multivariate analysis, factors predicting in-hospital mortality were age, preoperative cardiac troponin levels, and preoperative IABP. Age, preoperative cardiac troponin levels, and preoperative IABP use were predictive factors of in-hospital mortality in patients undergoing primary CABG for STEMI.

Entities:  

Mesh:

Year:  2010        PMID: 20462895     DOI: 10.1177/0003319710369103

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  6 in total

Review 1.  Protein localization in the plant Golgi apparatus and the trans-Golgi network.

Authors:  C Saint-Jore-Dupas; V Gomord; N Paris
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

Review 2.  [Surgical intramyocardial stem cell therapy for chronic ischemic heart failure].

Authors:  Alexander Kaminski; Peter Donndorf; Christian Klopsch; Gustav Steinhoff
Journal:  Herz       Date:  2010-08       Impact factor: 1.443

3.  Timing of coronary artery bypass surgery in patients with non-ST-segment elevation myocardial infarction and postoperative outcomes.

Authors:  Ismail Cihan Ozbek; Kenan Sever; Ozkan Demirhan; Denyan Mansuroglu; Muslum Cicek; Ebubekir Emre Men; Fusun Gunesdogdu; Murat Ugurlucan; Murat Basaran; Nuri Kurtoglu
Journal:  Arch Med Sci       Date:  2014-03-25       Impact factor: 3.318

4.  Optimal Timing of Surgical Revascularization for Myocardial Infarction and Left Ventricular Dysfunction.

Authors:  Rong Wang; Nan Cheng; Cang-Song Xiao; Yang Wu; Xiao-Yong Sai; Zhi-Yun Gong; Yao Wang; Chang-Qing Gao
Journal:  Chin Med J (Engl)       Date:  2017-02-20       Impact factor: 2.628

5.  Appropriate Timing of Coronary Artery Bypass Graft Surgery for Acute Myocardial Infarction Patients: A Meta-Analysis.

Authors:  Qianlei Lang; Chaoyi Qin; Wei Meng
Journal:  Front Cardiovasc Med       Date:  2022-03-28

6.  Release Profile of Cardiac Troponin T and Risk Factors of Postoperative Myocardial Injury in Patients Undergoing CABG.

Authors:  Yuying Gu; Lingtong Shan; Ban Liu; Mengwei Lv; Xi Chen; Tao Yan; Yu Shi; Jiapeng Chen; Zhi Li; Yangyang Zhang
Journal:  Int J Gen Med       Date:  2021-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.